{"id":1366,"date":"2020-05-13T18:06:16","date_gmt":"2020-05-13T16:06:16","guid":{"rendered":"http:\/\/invivo.partners\/?p=1366"},"modified":"2025-10-28T18:52:28","modified_gmt":"2025-10-28T17:52:28","slug":"orphan-drugs","status":"publish","type":"post","link":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/","title":{"rendered":"ORPHAN DRUGS"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">Most rare diseases still lack approved treatments despite major advances in the knowledge of their molecular basis. Here\u2019s a map of the different therapeutic modalities plus an update on some of the most interesting new developments in each field.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/twitter.com\/pareras\/status\/1259512030429675522\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>#quick_notes_LP<\/strong><\/a><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Most rare diseases still lack approved treatments despite major advances in the knowledge of their molecular basis. Here\u2019s a map of the different therapeutic modalities plus an update on some of the most interesting new developments in each field. #quick_notes_LP<\/p>\n","protected":false},"author":1,"featured_media":1364,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[584,590],"tags":[],"class_list":["post-1366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ideas-lab","category-ideas-lab-2-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ORPHAN DRUGS - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ORPHAN DRUGS - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Most rare diseases still lack approved treatments despite major advances in the knowledge of their molecular basis. Here\u2019s a map of the different therapeutic modalities plus an update on some of the most interesting new developments in each field. #quick_notes_LP\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-13T16:06:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T17:52:28+00:00\" \/>\n<meta name=\"author\" content=\"invivo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"invivo\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\"},\"author\":{\"name\":\"invivo\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\"},\"headline\":\"ORPHAN DRUGS\",\"datePublished\":\"2020-05-13T16:06:16+00:00\",\"dateModified\":\"2025-10-28T17:52:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\"},\"wordCount\":45,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Ideas Lab\",\"Ideas Lab\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\",\"url\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\",\"name\":\"ORPHAN DRUGS - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-05-13T16:06:16+00:00\",\"dateModified\":\"2025-10-28T17:52:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ORPHAN DRUGS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\",\"name\":\"invivo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"caption\":\"invivo\"},\"url\":\"https:\/\/invivo.partners\/es\/author\/invivocapital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ORPHAN DRUGS - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/","og_locale":"es_ES","og_type":"article","og_title":"ORPHAN DRUGS - Invivo Partners","og_description":"Most rare diseases still lack approved treatments despite major advances in the knowledge of their molecular basis. Here\u2019s a map of the different therapeutic modalities plus an update on some of the most interesting new developments in each field. #quick_notes_LP","og_url":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/","og_site_name":"Invivo Partners","article_published_time":"2020-05-13T16:06:16+00:00","article_modified_time":"2025-10-28T17:52:28+00:00","author":"invivo","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"invivo"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/"},"author":{"name":"invivo","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789"},"headline":"ORPHAN DRUGS","datePublished":"2020-05-13T16:06:16+00:00","dateModified":"2025-10-28T17:52:28+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/"},"wordCount":45,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Ideas Lab","Ideas Lab"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/","url":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/","name":"ORPHAN DRUGS - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-05-13T16:06:16+00:00","dateModified":"2025-10-28T17:52:28+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/2020\/05\/13\/orphan-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"ORPHAN DRUGS"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789","name":"invivo","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","caption":"invivo"},"url":"https:\/\/invivo.partners\/es\/author\/invivocapital\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/1366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/comments?post=1366"}],"version-history":[{"count":1,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/1366\/revisions"}],"predecessor-version":[{"id":1369,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/1366\/revisions\/1369"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media\/1364"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=1366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/categories?post=1366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tags?post=1366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}